EMERYVILLE, Calif.,
Oct. 1, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS),
a leading synthetic biotechnology company active in the Clean
Health and Beauty markets through its consumer brands, and a top
supplier of sustainable and natural ingredients, successfully
hosted the fourth webinar in its virtual investor mini-series. The
investor mini-series entitled "Lab-to-Market, Delivering
Disruptive Health and Beauty Products" was conducted via
live webcast and teleconference on Tuesday, September 28,
2021.
The livestreamed webinar, attended by more than 350 members of
the investor community featured John
Melo, President and Chief Executive Officer; Han Kieftenbeld, Chief Financial Officer;
Eduardo Alvarez, Chief Operating
Officer; Annie Tsong, Chief Product
and Technology Officer; Mike
Rytokoski, President Ingredients; and Alastair Dorward, Chief Brand Officer.
Mr. Melo described how Amyris is leading the Bio Revolution. He
provided an overview of Amyris' mission to accelerate the
transition to sustainable consumption, its business model and
advantaged portfolio, including a description of how the commitment
to sustainability is propelling adoption at scale through
technological leadership and manufacturing excellence; both key
components of the Company's Lab-to-Market™ operating
system.
Management described Amyris' Lab-to-Market operating system,
Knowledge Continuum (which is how data, information, and
intelligence come together) and the unique and powerful connection
between its ingredients portfolio and family of consumer brands –
the Portfolio Connection. The presentation concluded with case
studies about two beauty and personal care ingredients,
Hemisqualane, which is revolutionizing haircare and THC-free CBG
combined with Squalane and is showing promising results for a
number of inflammatory skin and joint conditions.
Presentation materials and a replay of the fourth investor
mini-series are available in the investor relations section of
Amyris's website at http://investors.amyris.com.
"This event continues our popular webinar series underscoring
Amyris' mission to accelerate the transition to sustainable
consumption through synthetic biology," commented Mr. Melo. "Amyris
has a clear and focused strategy and business model, world-class
partners, a proven record of success connecting our ingredients to
our consumer product portfolio, and unmatched knowledge and
experience optimized over 15 years from lab to market, all of which
are driving our competitive advantages of speed to market and
delivery at scale."
About Amyris
Amyris (Nasdaq: AMRS) is a science and
technology leader in the research, development and production of
sustainable ingredients for the Clean Health & Beauty and
Flavors & Fragrances markets. Amyris uses an impressive array
of exclusive technologies, including state-of-the-art machine
learning, robotics and artificial intelligence. Our ingredients are
included in over 20,000 products from the world's top brands,
reaching more than 300 million consumers. Amyris is proud to own
and operate a family of consumer brands - all built around its No
Compromise® promise of clean ingredients: Biossanceâ clean
beauty skincare, Pipetteâ clean baby skincare, Purecane™, a
zero-calorie sweetener naturally derived from sugarcane,
Terasanaâ clean skincare treatment, Costa Brazil luxury
skincare, OLIKA hygiene and wellness, Rose Inc.™ clean color
cosmetics and JVN™ clean haircare. For more information, please
visit http://www.amyris.com.
Amyris, the Amyris logo, No Compromise, Biossance, Pipette,
Purecane, Terasana, Rose Inc., JVN and Lab-to-Market are trademarks
or registered trademarks of Amyris, Inc. in the U.S. and/or other
countries.
View original
content:https://www.prnewswire.com/news-releases/amyris-hosts-successful-fourth-webinar-in-its-virtual-investor-mini-series-301389640.html
SOURCE Amyris, Inc.